The potential of 4D’s approach in curbing antimicrobial resistance among bacterial pathogens

  14 September 2022

This article intends to collate and discuss the potential of 4D’s (right Drug, Dose, Duration and De-escalation of therapy) approach to tackle the emerging problem of AMR. For this, we searched PubMed, Google Scholar, Medline, and clinicaltrials.gov databases primarily using the keywords “optimal antibiotic therapy”, “antimicrobial resistance”, “higher versus lower dose antibiotic treatment”, “shorter versus longer duration antibiotic treatment”, “de-escalation study” and “antimicrobial stewardship measures” and based on the findings, form and expressed our opinion.

Further reading: Taylor & Francis Online
Author(s): Lovnish Thakur et al
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

LifeArc

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





EADA 2023

Emerging Antimicrobials and Diagnostics in AMR 2023

International Matchmaking Symposium EADA 2023
Amsterdam, The Netherlands
16/17 November

More information
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!